Ann: CANNTAB GRANTED AUSTRALIAN PATENT, page-38

It's all moving in the right direction. I dropped off CGB about 2 years back. I think it will turn soon so I am interested in the next 3 months or so. Unfortunately those caught out it's a bit of a ways back. I got my last lot out at around 3.2 cents. Although I kicked myself for not selling it all at 10 cents lol.

Having said that I always said watch the Canntab share price as that will frontrun CGB. To date it is only a $38m company when it spikes to $300m market cap you know its on or even first leg to $100m.

I'm not sure what the profit margin would be but on $400k but I'd imagine at most 200% profit. So depends on how quickly they can ramp up sales.

All in all they seem to be growing a good mix between hemp sales in south east asia and alternative foods / vitamins.

I'm interested in the MS study from Israel too. Pretty much a large proportion of people with MS Smoke and a lot of people smoke for chronic pain relief. In terms of pain relief the Canntab pill only needs to capture a small amount of the market to have $m's in revenue given the size of the pain killer market.